Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Autologous cord blood in children with cerebral palsy: a review.

Boruczkowski D, Pujal JM, Zdolińska-Malinowska I.

Int J Mol Sci. 2019 May 16;20(10). pii: E2433. doi: 10.3390/ijms20102433. Review.

2.

Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.

Monguió-Tortajada M, Roura S, Gálvez-Montón C, Pujal JM, Aran G, Sanjurjo L, Franquesa M, Sarrias MR, Bayes-Genis A, Borràs FE.

Theranostics. 2017 Jan 1;7(2):270-284. doi: 10.7150/thno.16154. eCollection 2017.

3.

Quality and exploitation of umbilical cord blood for cell therapy: Are we beyond our capabilities?

Roura S, Pujal JM, Gálvez-Montón C, Bayes-Genis A.

Dev Dyn. 2016 Jul;245(7):710-7. doi: 10.1002/dvdy.24408. Epub 2016 Apr 28. Review.

4.

The role and potential of umbilical cord blood in an era of new therapies: a review.

Roura S, Pujal JM, Gálvez-Montón C, Bayes-Genis A.

Stem Cell Res Ther. 2015 Jul 2;6:123. doi: 10.1186/s13287-015-0113-2. Review.

5.

Impact of umbilical cord blood-derived mesenchymal stem cells on cardiovascular research.

Roura S, Pujal JM, Gálvez-Montón C, Bayes-Genis A.

Biomed Res Int. 2015;2015:975302. doi: 10.1155/2015/975302. Epub 2015 Mar 10. Review.

6.

Fetal-maternal interface: a chronicle of allogeneic coexistence.

Pujal JM, Roura S, Muñoz-Marmol AM, Mate JL, Bayes-Genis A.

Chimerism. 2012 Jan-Mar;3(1):18-20.

7.

Umbilical cord blood for cardiovascular cell therapy: from promise to fact.

Roura S, Pujal JM, Bayes-Genis A.

Ann N Y Acad Sci. 2012 Apr;1254:66-70. doi: 10.1111/j.1749-6632.2012.06515.x. Review.

PMID:
22548571
8.

Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.

Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T.

J Neurol Sci. 2010 Nov 15;298(1-2):96-100. doi: 10.1016/j.jns.2010.07.026. Epub 2010 Sep 1.

PMID:
20810130
9.

Should microchimerism turn into rejection prophylactics?

Pujal JM.

Expert Rev Mol Diagn. 2010 Jan;10(1):107-18. doi: 10.1586/erm.09.79. Review.

PMID:
20014925
10.

PCR-based methodology for molecular microchimerism detection and quantification.

Pujal JM, Gallardo D.

Exp Biol Med (Maywood). 2008 Sep;233(9):1161-70. doi: 10.3181/0802-RM-35. Epub 2008 Jun 5.

PMID:
18535170
11.

Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation.

Pujal JM, Grinyó JM, Gil-Vernet S, Caldes A, Hernández P, Mestre M, Encuentra M, Perez-Garcia A, Gallardo D.

Transplantation. 2007 Nov 15;84(9):1103-11.

PMID:
17998864

Supplemental Content

Loading ...
Support Center